Healthpeak Properties, Inc. (NYSE:DOC) Stock Holdings Reduced by JPMorgan Chase & Co.

Key Points

• JPMorgan Chase & Co. reduced its stake in Healthpeak Properties by 16.2% during the first quarter, following the sale of 3,182,853 shares, leaving them with approximately 2.37% ownership valued at $333.3 million.
• Several institutional investors increased their holdings in Healthpeak Properties, with Wells Fargo & Company boosting its stake by **20.9%**, while over **93%** of the stock is now owned by institutional investors.
• Healthpeak Properties recently announced a monthly dividend of **$0.1017**, with a significant dividend yield of **7.2%**, while maintaining a high dividend payout ratio of **508.33%**.

JPMorgan Chase & Co. lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 16.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,483,663 shares of the real estate investment trust's stock after selling 3,182,853 shares during the quarter. JPMorgan Chase & Co. owned approximately 2.37% of Healthpeak Properties worth $333,300,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DOC. TCTC Holdings LLC boosted its position in Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the period. Future Financial Wealth Managment LLC acquired a new position in Healthpeak Properties during the 1st quarter worth $30,000. S.A. Mason LLC boosted its position in Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after acquiring an additional 925 shares during the period. Covestor Ltd boosted its position in Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,152 shares during the period. Finally, Beacon Capital Management LLC boosted its position in Healthpeak Properties by 138.3% during the 1st quarter. Beacon Capital Management LLC now owns 1,816 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,054 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Trading Up 1.6%

Shares of Healthpeak Properties stock traded up $0.28 on Friday, reaching $17.32. 6,201,670 shares of the company were exchanged, compared to its average volume of 8,335,443. The stock has a fifty day moving average price of $17.64 and a 200-day moving average price of $18.49. The firm has a market capitalization of $12.04 billion, a price-to-earnings ratio of 72.17, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%. Healthpeak Properties's revenue for the quarter was down .2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.45 earnings per share. On average, analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, August 18th. This represents a dividend yield of 705.0%. Healthpeak Properties's payout ratio is 508.33%.

Insiders Place Their Bets

In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,777 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The shares were purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Scott M. Brinker purchased 1,490 shares of the company's stock in a transaction that occurred on Monday, August 4th. The shares were acquired at an average cost of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the transaction, the chief executive officer directly owned 211,906 shares of the company's stock, valued at $3,566,377.98. This trade represents a 0.71% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 14,560 shares of company stock worth $249,898 over the last ninety days. 0.23% of the stock is owned by insiders.

Analyst Ratings Changes

DOC has been the subject of a number of analyst reports. Wedbush reduced their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Argus reiterated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Robert W. Baird set a $21.00 price target on Healthpeak Properties and gave the stock an "outperform" rating in a research report on Wednesday, July 30th. Evercore ISI reduced their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Scotiabank lowered Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their price target for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.00.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.